Ji Li, Ph.D., is a Venture Partner with Lilly Asia Ventures (LAV). Prior to joining LAV, Ji was most recently Executive VP and Global Head of Business Development at BeiGene; prior to that, Ji was VP of Business Development and Licensing at Merck; earlier in his career, Ji was Executive Director of External R&D at Amgen. Ji has over 21 years of industry experience and brings to LAV strong expertise in biopharmaceutical business development and R&D. Ji holds a Ph.D. in Neuroscience from Mount Sinai School of Medicine, and a B.S. in Pharmacology from Shanghai Medical University.